Smarter Bioprocess Design for Smoother Scale Up

Our Chief Scientific Officer, Daniel Galbraith recently spoke to Biocompare about ‘Smarter Bioprocess Design for Smoother Upscale’. To read the full article, click here.

Sign-up to receive 3 tips on improving
speed to clinic for biosimilars

Sign-up to receive 3 tips on improving
speed to clinic for biosimilars

* you agree to receive emails with tips, news, insights and quizzes.